Immunoarchitectural characterization of a human skin model reconstructed in vitro
Keywords:
Burns, Cytokeratin, Immunohistochemistry, Skin transplantation, Tissue engineeringAbstract
CONTEXT AND OBJECTIVE: Over the last few years, different models for human skin equivalent reconstructed in vitro (HSERIV) have been reported for clinical usage and applications in research for the pharmaceutical industry. Before release for routine use as human skin replacements, HSERIV models need to be tested regarding their similarity with in vivo skin, using morphological (architectural) and immunohistochemical (functional) analyses. A model for HSERIV has been developed in our hospital, and our aim here was to further characterize its immunoarchitectural features by comparing them with human skin, before it can be tested for clinical use, e.g. for severe burns or wounds, whenever ancillary methods are not indicated. DESIGN AND SETTING: Experimental laboratory study, in the Skin Cell Culture Laboratory, School of Medical Sciences, Universidade Estadual de Campinas. METHODS: Histological sections were stained with hematoxylin-eosin, Masson’s trichrome for collagen fibers, periodic acid-Schiff reagent for basement membrane and glycogen, Weigert-Van Gieson for elastic fibers and Fontana-Masson for melanocytes. Immunohistochemistry was used to localize cytokeratins (broad spectrum of molecular weight, AE1/AE3), high molecular weight cytokeratins (34βE12), low molecular weight cytokeratins (35βH11), cytokeratins 7 and 20, vimentin, S-100 protein (for melanocytic and dendritic cells), CD68 (KP1, histiocytes) and CD34 (QBend, endothelium). RESULTS: Histology revealed satisfactory similarity between HSERIV and in vivo skin. Immunohistochemical analysis on HSERIV demonstrated that the marker pattern was similar to what is generally present in human skin in vivo. CONCLUSION: HSERIV is morphologically and functionally compatible with human skin observed in vivo.
Downloads
References
Kim BM, Suzuki S, Nishimura Y, et al. Cellular artificial skin substitute produced by short period simultaneous culture of fibroblasts and keratinocytes. Br J Plast Surg. 1999;52(7):573-8.
Kremer M, Lang E, Berger AC. Evaluation of dermal-epidermal skin equivalents (‘composite- skin’) of human keratinocytes in a collagen-glycosaminoglycan matrix(Integra artificial skin). Br J Plast Surg. 2000;53(6):459-65.
Hoeller D, Huppertz B, Roos TC, et al. An improved and rapid method to reconstruct skin equivalents from human hair follicles and fibroblasts. Exp Dermatol. 2001;10(4):264-71.
Jansson K, Haegerstrand A, Kratz G. A biodegradable bovine collagen membrane as a der- mal template for human in vivo wound healing. Scand J Plast Reconstr Surg Hand Surg. 2001;35(4):369-75.
Navsaria HA, Ojeh NO, Moiemen N, Griffiths MA, Frame JD. Reepithelialization of a full- thickness burn from stem cells of hair follicles micrografted into a tissue-engineered dermal template (Integra). Plast Reconstr Surg. 2004;113(3):978-81.
Souto LR, Rehder J, Vassallo J, Cintra ML, Kraemer MH, Puzzi MB. Model for human skin reconstructed in vitro composed of associated dermis and epidermis. Sao Paulo Med J. 2006;124(2):71-6.
Ponec M. In vitro cultured human skin cells as alternatives to animals for skin irritancy screening. Int J Cosmet Sci. 1992;14(6):245-64. Available from: http://www3.interscience. wiley.com/cgi-bin/fulltext/119984942/PDFSTART. Accessed in 2008 (Dec 23).
Ponec M, Boelsma E, Gibbs S, Mommaas M. Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol. 2002;15(Suppl 1):4-17.
Mirastschijski U, Bugdahl R, Rollman O, Johansson BR, Agren MS. Epithelial regeneration from bioengineered skin explants in culture. Br J Dermatol. 2006;154(1):42-9.
Stock UA, Vacanti JP. Tissue engineering: current state and prospects. Annu Rev Med. 2001;52:443-51.
Ponec M, Gibbs S, Pilgram G, et al. Barrier function in reconstructed epidermis and its re- semblance to native human skin. Skin Pharmacol Appl Skin Physiol. 2001;14(Suppl 1):63- 71.
Régnier M, Asselineau D, Lenoir MC. Human epidermis reconstructed on dermal substrates in vitro: an alternative to animals in skin pharmacology. Skin Pharmacol. 1990;3(2):70- 85.
Helm KF. Immunohistochemistry of skin tumors. In: Dabbs D, editor. Diagnostic immunohis- tochemistry. 1st ed. Philadelphia: Churchill Livingstone; 2002. p.313-32.
Eichner R, Bonitz P, Sun TT. Classification of epidermal keratins according to their immuno- reactivity, isoelectric point, and mode of expression. J Cell Biol. 1984;98(4):1388-96.
Régnier M, Pruniéras M, Woodley D. Growth and differentiation of adult human epidermal cells on dermal substrates. Front Matrix Biol. 1981;9:4-35.
El Ghalbzouri A, Jonkman MF, Dijkman R, Ponec M. Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated kerati- nocytes. J Invest Dermatol. 2005;124(1):79-86.
Dean NR, Brennan J, Haynes J, Goddard C, Cooter RD. Immunohistochemical labeling of normal melanocytes. Appl Immunohistochem Mol Morphol. 2002;10(3):199-204.
Bessou S, Pain C, Taïeb A. Use of human skin reconstructs in the study of pigment modifiers. Arch Dermatol. 1997;133(3):331-6.
Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40(5):403-39.
Bhawan J, Whren K, Panova I, Yaar M. Keratin 16 expression in epidermal melanocytes of normal human skin. Am J Dermatopathol. 2005;27(6):476-81.
Dale BA, Holbrook KA. Developmental expression of human epidermal keratins and filaggrin. Curr Top Dev Biol. 1987;22:127-51.
Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and tricho- epithelioma. Am J Dermatopathol. 1999;21(4):332-6.
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31(1): 11-24.
Böni R, Burg G, Doguoglu A, et al. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol. 1997;137(1):39-43.
Smith ME, Costa MJ, Weiss SW. Evaluation of CD68 and other histiocytic antigens in angio- matoid malignant fibrous histiocytoma. Am J Surg Pathol. 1991;15(8):757-63.
Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, der- mal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi’s sarcoma. Arch Dermatol. 1991;127(4):523-9.
